Daiichi Sankyo Company, Limited

4568.T
Drug Manufacturers - General
2026/09/25 10:48 Updated
Market Cap: $33.9B (¥5.3T)
Stock Price: $18.62 (¥2,933)
Exchange Rate: 1 USD = ¥157.48

Notice of Filing an Appeal Against NTK’s Claim for Damages and Other Relief

NTK filed an appeal, moving the case to the Tokyo High Court. The lower court ruled in favor of Daiichi Sankyo. The appeal concerns claims totaling 2,033 hundred million yen; the impact on future results is under review.

Importance:
Page Updated: September 28, 2026
IR Disclosure Date: September 28, 2026

Key Figures

  • Claim Amount: 2,033 hundred million yen 1,807,840 yen
  • Date of Appeal Filing: September 24, 2026
  • Judgment Date: September 10, 2026 (Tokyo District Court)

AI要約

Current Status of the Litigation and Appeal

Daiichi Sankyo announced that, in the judgment dated September 10, 2026, NTK's claims were dismissed. Subsequently, NTK has filed an appeal to the Tokyo High Court, which was disclosed today. The appeal covers claims for damages, requests for injunctive relief to prevent interference, requests to post information, and other matters, with the claimed amount stated as 2,033 hundred million yen 1,807,840 yen. The effect on consolidated results is currently being examined, and any additional disclosures will be made promptly.

Outlook and Impact

The outcome of the appellate proceedings is undecided, and the company will continue to maintain the validity of the first-instance judgment. Any direct financial impact on the company is currently undetermined, and additional information will be disclosed as developments occur. The legal proceedings involve complexities including connections to India, leaving the timeline and cost outlook unknown.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daiichi Sankyo Company, Limited

Company overview · Stock price · Financial data · All IR

View company page →